Autologous stem cell therapy in cardiovascular disease - Experiences in Düsseldorf;Stammzelltherapie bei kardiovaskulären erkrankungen - Düsseldorfer erfahrungen

Deutsche Medizinische Wochenschrift

Volumn 133, Issue 50 SUPPL. 8, 2008, Pages

  Schannwell, Christiana Mira ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Klinik fur Kardiologie   (Germany)

Author keywords

Autologous stem cell therapy; Coronary artery disease; Dilated cardiomyopathe; Heart failure; Peripherial artery disease

Indexed keywords

DIPYRIDAMOLE; DOBUTAMINE;

ARTERY DISEASE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BALLOON DILATATION; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; CORONARY STENT; FIBROSIS; HEART FAILURE; HEART INFARCTION; HUMAN; LOW DRUG DOSE; MUSCLE HYPERTROPHY; REVIEW;

ADULT STEM CELLS; ANIMALS; ARTERIAL OCCLUSIVE DISEASES; BONE MARROW TRANSPLANTATION; CARDIOMYOPATHY, DILATED; CARDIOVASCULAR DISEASES; CORONARY DISEASE; GERMANY; HEART; HEART FAILURE; HUMANS; MULTIPOTENT STEM CELLS; MYOCARDIAL INFARCTION; PERIPHERAL VASCULAR DISEASES; PROGNOSIS; QUALITY OF LIFE; REGENERATION; TRANSPLANTATION, AUTOLOGOUS;

EID: 57849143950     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1100961     Document Type: Review

References (42)

1. Assmus B, Schächinger V, Teupe C et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPECARE-AMI). Circulation 2002; 106: 3009-17
2. Bartsch T, Brehm M, Zeus T et al. Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (the TAM-PAD study). Clin Res Cardiol 2007; 96: 891-899
3. Brehm M, Zeus T, Strauer BE. Stem cells - clinical application and perspectives. Herz 2002; 27 (7): 611-20
4. Condorelli G, Borello U, De Angelis L et al. Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration. Proc Natl Acad Sci U S A 2001; 98: 10733-10738
5. Felix R, Pensky W, Wagner J et al. Das selektive koronare Perfusionsszintigramm. Dtsch Med Wochenschr 1974; 99: 2258-2261
6. Felix R, Simon H, Hedde JP, Winkler C. Die myokardiale Perfusionsszintigraphie Methodik und Grundlagen. Nucl Med 1978; 4: 172-177
7. Fuster V, Gersh BJ, Guiliani E. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981; 47: 525-
8. Goodell MA, Jackson KA, Majka SM et al. Stem cell plasticity in muscle and bone marrow. Ann N Y Acad Sci 2001; 938: 208-218
9. Heidland UE, Heintzen MP, Strauer BE. Ischämische Präkonditionierung: Möglichkeiten und Grenzen der Analyse und Nutzung der endogenen Myokardprotektion beim Menschen. Dtsch Med Wochenschr 1997; 122: 65-70
10. Jiang Y, Jahagirdar B, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 20: 1-12
11. Kocher AA, Schuster MD, Szabolcs MJ et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7: 430-436
12. Konstam V, Salem D, Pouleur H et al. Baseline quality of life as a predictor of mortality and hospitalization in 5025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators. Am J Cardiol 1996; 78: 890-895
13. Lenk K, Adams V, Lurz P et al. Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia. Eur Heart J 2005; 26: 1903-1909
14. Levy D. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002; 347: 1397-
15. Lipinski MJ, Biondi-Zoccai GG, Abbate A et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematzic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 2007; 50: 1761-1767
16. Lunde K, Solheim S, Aakhus S et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006; 355: 1199-1209
17. Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701-705
18. Orlic D, Kajstura J, Chimenti S et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 2001; 98: 10344-10349
19. Penn MS, Zhang M, Deglurkar I, Topol EJ. Role of stem cell homing in myocardial regeneration. Int J Cardiol 2004; 95 Suppl 1: S23-5
20. Pittinger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147
21. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004; 95 (1): 9-20. Review
22. Quaini F, Urbanek K, Beltrami AP et al. Chimerism of the transplanted heart. N Engl J Med 2002; 346: 5-15
23. Reyes M, Lund T, Lenvik T et al. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001; 98: 2615-2625
24. Rich MW, Nease RF. Cost-effectiveness analysis in clinical practice. The case of heart failure. Arch Intern Med 1999; 159: 1690-1700
25. Schachinger V, Erbs S, Elsasser A et al. REPAIR-AMI Investigators. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006; 55: 1210-1221
26. Schannwell CM, Ott G, Brehm M et al. Five years experience with autologous intracoronary stem cell transplantation. Current status and perspectives. Internist 2006; 47: 1087-1088
27. Schannwell CM, Brehm M, Zeus T et al. Stem Cell Therapy in chronic heart failure. 7th International Congress on Coronary Artery Disease - ICCAD, 2007: 3-11.
28. Schannwell CM, Köstering M, Zeus T et al. Humane autologe intrakoronare Stammzelltransplantation zur Myokardregeneration bei dilatativer Kardiomyopathie (NYHA Stadium II bis III) Düsseldorfer Autologous Bone Marrow Cells in Dilated Cardiomyopathy Trial (Düsseldorfer-ABCD Trial). J Kardiol, 2008 in press
29. Schüller PO, Meyer C, Brehm M et al. Intracoronary autologous bone marrow cell transplantation beneficially modulates heart rate variability. Int J Cardiol 2007; 119: 398-399
30. Seth S, Narang R, Bhargava B et al. Venugopal P for the AIIMS Cardiovascular Stemm Cell Study Group. Percutaneous Intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathological results: the First-in-Man ABCD (autologous bone marrow cells in dilated cardiomyopathy) Trial. J Am Coll Cardiol 2006; 48: 2350-2351
31. Strauer BE, Brehm M, Zeus T et al. Intrakoronare, humane autologe Stammzelltransplantation zur Myokarddegeneration nach Herzinfarkt. Dtsch Med Wochenschr 2001; 126: 932-8
32. Strauer BE, Brehm M, Zeus T et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106: 1913-1918
33. Strauer BE, Brehm M, Zeus T et al. Stem cell therapy in acute myocardial infarction. Med Klin 2003; 98 Suppl 2: 14-18
34. Strauer BE, Brehm M, Zeus T et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease. The IACT Study. J Am Coll Cardiol 2005; 46: 1651-1658
35. Strauer BE, Brehm M, Schannwell CM. The therapeutic potential of stem cells in heart disease. Cell Prolif 2008; 41 Suppl 1: 126-145
36. Strauer BE, Heidland UE, Heintzen MP, Schwartzkopff B. Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performance. J Am Coll Cardiol 1996; 28: 1119-1126
37. Strauer BE, Heidland UE, Vogt M et al. Protektion und "Preconditioning" des menschlichen Herzens während perkutaner transluminaler Coronarangioplastie durch intrakoronare Dipyridamol-Applikation. Med Klin 1995; 90: 125-130
38. Tateishi-Yuyama E, Matsubara H, Murohara T et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002; 360: 427-435
39. Tomita S, Li RK, Weisel RD et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999; 100 (suppl II): 247-256
40. Tomita S, Mickle DA, Weisel RD et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromalcell transplantation. J Thorac Cardiovasc Surg 2002; 123: 1132-1135
41. Wollert KC, Meyer GP, Lotz J et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004; 364: 141-148
42. Yusuf S, Pfeffer MA, Swedberg K et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003; 362: 777-781